SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to fresh lows is being discussed alongside President Trumps waiver of Russia-related sanctions and tariffs, which has intensified criticism of his Russia policy and broader political and economic turmoil. Some traders see an oversold bounce setup, while others point to weak company prospects and expect further declines.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Hotter-than-expected inflation and renewed rate-hike concerns are weighing on rate-sensitive small caps, with IWM under pressure as the Russell 2000 pulls back. Traders are split between expecting an oversold bounce and anticipating further losses, while put-heavy positioning reflects caution.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is drawing attention amid a selloff that traders associate with a reported RBC downgrade and concerns that Pharvariss HAE results could intensify competition for Orladeyo. Some investors view the decline as an overreaction given Orladeyos growth and BioCrysts pipeline, while others criticize managements acquisition strategy and see Navenibarts results as a key test.

Pump.fun

PUMP.funs token is drawing attention for its volatile price action and the possibility of a sustained rebound. Traders cite platform revenue-funded buybacks and burns as a bullish support, while others point to selloffs, token unlocks, and broader meme-coin risks.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

NVAXs sharp selloff has traders weighing Shah Capitals disclosed share sale and step back from activism against Citis reiterated Sell rating, broader biotech weakness, and a TipRanks report many say recycled a resolved 2024 FDA hold as new. Some blame those headlines and market conditions, while others allege options-related or short-selling pressure; those claims of coordination remain unproven.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Discussion centers on Zebecs reported expansion of enterprise USDC payroll on Stellar and other payment integrations, which bullish traders view as signs of adoption. Others argue that partnerships have yet to translate into stronger ZBCN performance, citing weak volume and persistent price declines.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

XCN is drawing attention after a steep pullback, with traders focused on broken support, trend-line resistance and unusually low volume. Some see oversold technical signals as a setup for a rebound and are buying dips, while others say repeated drops and difficulty holding gains undermine confidence; some attribute the weakness to Bitcoin and the broader crypto market.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm is caught in a broader semiconductor and AI-stock pullback, with traders debating its stretched valuation and whether AI spending and growth expectations can justify it. Some see the weakness as a buying opportunity, pointing to long-term demand for Arm-based CPUs and AI infrastructure.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Discussion centers on Compounds institutional push, including a reported $52 million finance program, new leadership, and an institutional-market launch, alongside optimism about the V4 roadmap and limited token supply. Traders are split between accumulating in anticipation of a breakout and criticizing COMPs weak, volatile price action and lagging performance versus other crypto assets.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Crudes climb amid persistent geopolitical supply concerns is drawing attention to UCO, with traders also discussing uncertainty around Russia-related sanctions and diesel supplies. Oil bulls point to supply risks, while others expect pullbacks and caution that UCOs leverage can amplify swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why You Should Add LPCN Stock to Your Portfolio Now

Lipocine's Tlando royalties, Brlizio's phase III trial and broader pipeline offer multiple potential growth drivers and catalysts.

Nasdaq Falls Over 100 Points; US Crude Inventories Decline

U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciencesread more...

Oral Testosterone Capsule Wins Canadian Approval, Shares Up

Testosterone replacement therapy has largely relied on delivery methods that come with practical tradeoffs. Injections require needles and can cause injection-site reactions, while topical gels can be messy and carry a risk of transferring testosterone to others through skin contact. An oral treatment that does not require dose titration offers another approach in a Canadian market where more than 700,000 testosterone replacement therapy prescriptions are written annually.Shares of Lipocine Inc. (NASDAQ: LPCN) are moving higher Wednesday after the company announced that Health Canada has ...

Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement Therapy

Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement Therapy Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement TherapyPR NewswireSALT LAKE CITY, Oct. 7, 2026SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a...

Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?

Lipocine (LPCN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression

Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum DepressionPR NewswireSALT LAKE CITY, Sept. 14, 2026 Study informed by encouraging exploratory efficacy findings and a...

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire SALT LAKE CITY, Sept. 10, 2026 SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty...

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 PR Newswire SALT LAKE CITY, Aug. 4, 2026 SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty...

Lipocine Appoints Michael J. Grissinger to Board of Directors

Lipocine Appoints Michael J. Grissinger to Board of Directors Lipocine Appoints Michael J. Grissinger to Board of Directors PR Newswire SALT LAKE CITY, Aug. 3, 2026 SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary...

• Reported GAAP EPS of -$0.32 up 21.95% YoY
• Reported revenue of $0.19M down -69.48% YoY

Lipocine Inc. faces significant challenges including failure to meet the primary endpoint in a Phase 3 trial, data validity concerns at a clinical site, and a widening quarterly net loss.

Lipocine Inc. demonstrated potential efficacy for LPCN 1154 in post hoc analysis, initiated a new clinical trial, and achieved international regulatory approval for TLANDO in the United Arab Emirates.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

LPCN Stock Crashes 78%— Here’s Why 

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.56
Prev Close	$1.68
Open	$1.66
Dividend Yield	0.00%
50-Day Moving Average	$2.10
Beta	0.73
Avg. Volume	33,440.80
PE Ratio	-0.84

52-Week High	$12.37
52-Week Low	$1.48
Market Capitalization	$12.86M
EPS (Annual)	-$1.77
Price to Book	0.59
Revenue Per Employee	$141,191.21

Feed

News

Sentiment

Earnings

Fundamentals

Info

LPCN Fundamentals